Alamelu Mangai Thiraviam

Title: Alamelu Mangai Thiraviam: Innovating Respiratory Treatments in Navi Mumbai

Introduction

Alamelu Mangai Thiraviam, based in Navi Mumbai, India, is a notable inventor in the pharmacological field. With a focus on innovative treatments for respiratory disorders, Thiraviam has made significant contributions to the healthcare industry through her research and inventions.

Latest Patents

Thiraviam holds a patent for the treatment of respiratory disorders utilizing ROR-gamma inhibitors. This patent describes a novel approach involving retinoid-related orphan receptor gamma t (ROR-gamma) modulators. Specifically, the invention centers on administering ROR-gamma inhibitors via an inhalation route, targeting subjects in need of effective respiratory disorder treatments.

Career Highlights

Alamelu Mangai Thiraviam is currently working with Glenmark Pharmaceuticals S.A. Here, she has been able to put her innovative concepts into practice, contributing to advancements in respiratory medicine. Her dedication to developing effective treatments showcases her profound commitment to improving patient outcomes.

Collaborations

During her career, Thiraviam has collaborated with talented colleagues such as Neelima Khairatkar-Joshi and Abhay Kulkarni. These partnerships have fostered a collaborative environment that encourages innovative problem-solving and the development of cutting-edge pharmaceutical solutions.

Conclusion

Alamelu Mangai Thiraviam's work exemplifies the power of innovation within the pharmaceutical industry. Her patent on ROR-gamma inhibitors not only highlights her creativity as an inventor but also her contribution to addressing serious health challenges associated with respiratory disorders. Through her ongoing efforts and collaborations, Thiraviam continues to pave the way for future advancements in healthcare.